Psychiatry in Arlington, TX
15 verified psychiatry doctors in Arlington.
Psychiatrists are physicians who diagnose and treat mental health conditions, including through medication management.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Wasiq Zaidi, MD
Psychiatry
CMS Open Payments· $34,667 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$34,667
Total received
172
Transactions
19
Paying companies
Top paying companies
Among the 57,336 psychiatry doctors we've analyzed, about 24% received any industry payment (median $180 among those who did). This doctor's total is higher than 99% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US psychiatry doctors.
Payments to Wasiq Zaidi do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Quazi Imam, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Annette Shelton, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Hemant Day, MD
Psychiatry
CMS Open Payments· $46.07 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$46.07
Total received
2
Transactions
2
Paying companies
Top paying companies
Among the 57,336 psychiatry doctors we've analyzed, about 24% received any industry payment (median $180 among those who did). This doctor's total ranks around the 81th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US psychiatry doctors.
Payments to Hemant Day do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Robert Mims, MD
Psychiatry
CMS Open Payments· $1,044 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,044
Total received
33
Transactions
7
Paying companies
Top paying companies
Among the 57,336 psychiatry doctors we've analyzed, about 24% received any industry payment (median $180 among those who did). This doctor's total is higher than 95% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US psychiatry doctors.
Payments to Robert Mims do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Rupinder Bhatia, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Robert Knipstein, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Sylvia Moring, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Andrew Klymiuk, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Stephen Barksdale, MD
Psychiatry
CMS Open Payments· $244.14 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$244.14
Total received
3
Transactions
2
Paying companies
Top paying companies
Among the 57,336 psychiatry doctors we've analyzed, about 24% received any industry payment (median $180 among those who did). This doctor's total ranks around the 89th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US psychiatry doctors.
Payments to Stephen Barksdale do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Jacqueline Curtis, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Hakan Sahin, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Paresh Jaini, DO
Psychiatry
CMS Open Payments· $46.05 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$46.05
Total received
3
Transactions
3
Paying companies
Top paying companies
Among the 57,336 psychiatry doctors we've analyzed, about 24% received any industry payment (median $180 among those who did). This doctor's total ranks around the 81th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US psychiatry doctors.
Payments to Paresh Jaini do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Sulaimon Bakre, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Beth Kirundu, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.